ReviewBioImpacts : BI2022

Recent advances in cancer immunotherapy: Modulation of tumor microenvironment by Toll-like receptor ligands.

Leila Rostamizadeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.